Dialysis Patients' Hb Levels Decline

May 2013
Renal & Urology News;May2013, Vol. 12 Issue 5, p18
The article presents the study regarding the decreased levels of hemoglobin (Hb) and increased rates of transfusion of dialysis patients after the introduction of medicare prospective payment system for end-stage renal disease (ESRD) care. It states that Hb levels decline in June 2010 to April 2012 while transfusion rates of patients increased. It also mentions that percentage of patients who received transfusion has increased among medicare patients than insured patients.


Related Articles

  • Medicare End Stage Renal Disease Program Enrollment: CYs 1978-93.  // Health Care Financing Review;Summer95 Supplement, Vol. 16, p114 

    The article focuses on the Medicare End Stage Renal Disease (ESRD) Program Enrollment from 1978 to 1993 in the U.S. Within the period, the number of beneficiaries with ESRD has grown rapidly since the beginning of the program. In 1993, Medicare ESRD beneficiaries consisted of 173,181 persons...

  • Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease. Warady, Bradley; Silverstein, Douglas // Pediatric Nephrology;Sep2014, Vol. 29 Issue 9, p1493 

    Anemia management is an important component of the care provided to children with chronic kidney disease (CKD) and influences both morbidity and mortality risk. The introduction of recombinant human erythropoietin to the treatment regimen three decades ago revolutionized the therapy and...

  • Race Strongly Associated with Family Histories of ESRD.  // Kidney;Jul/Aug98, Vol. 7 Issue 4, p164 

    Presents a summary of the article 'Family History of End-Stage Renal Disease Among Incident Dialysis Patients,' by B.I. Freedman, J.M. Soucie et al published in 'Journal of American Society of Nephrology' periodical.

  • A prospective cohort study of incident maintenance dialysis in children: An NAPRTC study1. Leonard, Mary B.; Donaldson, Lynn A.; Ho, Martin; Geary, Denis F. // Kidney International;Feb2003, Vol. 63 Issue 2, p744 

    A prospective cohort study of incident maintenance dialysis in children: An NAPRTC Study. Background. Prior studies of dialysis practices and outcomes have included children with varied duration of end-stage renal disease (ESRD). This study evaluated dialysis characteristics, complications,...

  • Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease. Johansen, Kirsten L.; Painter, Patricia; Kent-Braun, Jane A.; Ng, Alexander V.; Carey, Susan; da Silva, Makani; Chertow, Glenn M. // Kidney International;Mar2001, Vol. 59 Issue 3, p1121 

    Assess the validity of end-stage renal disease (ERSD) of several questionnaires designed to measure physical activity or physical functioning in San Francisco, California. Scores of dialysis patients; Lack of valid measures of physical activity; Characteristics of study subjects.

  • The final word. Greca, Giuseppe La; Klinkmann, Horst; Valderrabano, Fernando; Zucchelli, Pietro // Kidney International Supplement;Aug2000, Issue 76, pS-156 

    Focuses on the importance of dialysis treatment. Reduction of cardiovascular and atherosclerotic risk factors; Prevention of complication in the end-stage renal disease patient; Control of the nutritional status of the patients.

  • Prevalence and predictors of the sub-target Hb level in children on dialysis†. van Stralen, Karlijn J.; Krischock, Leah; Schaefer, Franz; Verrina, Enrico; Groothoff, Jaap W.; Evans, Jonathan; Heaf, James; Ivanov, Dimitar; Kostic, Mirjana; Maringhini, Silvio; Podracká, Ludmila; Printza, Nikoleta; Pundziene, Birute; Reusz, Gyorgy S.; Vondrak, Karel; Jager, Kitty J.; Tizard, and E. Jane // Nephrology Dialysis Transplantation;Oct2012, Vol. 27 Issue 10, p3950 

    Background Anaemia is a common and potentially treatable co-morbidity of end-stage renal disease. We aimed to determine the prevalence of the sub-target haemoglobin (Hb) level among European children on dialysis and to identify factors associated with a low Hb level. Methods From the European...

  • Use of Intravenous Iron Supplementation in Chronic Kidney Disease An Update. Macdougall, Iain C.; Geisser, Peter // Iranian Journal of Kidney Diseases;Jan2013, Vol. 7 Issue 1, p9 

    Iron deficiency is an important clinical concern in chronic kidney disease (CKD), giving rise to iron-deficiency anemia and impaired cellular function. Oral supplementation, in particular with ferrous salts, is associated with a high rate of gastrointestinal side effects and is poorly absorbed,...

  • Reply. Rosenstock, Jordan L. // Nephrology Dialysis Transplantation;Mar2011, Vol. 26 Issue 3, p1112 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics